The Mechanism of Action of cTIND for Minimally Invasive Ischemic Incision of the Prostate: In Vivo Study - ScienceDirect
By A Mystery Man Writer
Description
Harnessing the potential of multimodal radiotherapy in prostate
Study Published in Nature Provides Path for New Immunotherapy to
The Mechanism of Action of cTIND for Minimally Invasive Ischemic
Prostate Surgery - an overview
Minimally Invasive Surgical Approaches and Management of Prostate
Lobe-Specific Carcinogenesis in the Transgenic Adenocarcinoma of
Prostate Surgery - an overview
Acute and late toxicity and preliminary outcomes report of
Silk fibroin peptide self-assembled nanofibers delivered
Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer, BMC Cancer
Experimental in vitro, ex vivo and in vivo models in prostate
Harnessing the potential of multimodal radiotherapy in prostate
The Mechanism of Action of cTIND for Minimally Invasive Ischemic
IJMS, Free Full-Text
from
per adult (price varies by group size)